Rapid testsAMP Diagnostics (AMEDA Labordiagnostik, Austria)

AMP – SARS-CoV-2 Ag, nasopharyngeal

Antigen rapid test · nasopharyngeal swab · 10 tests per box

Rapid immunochromatographic test for the qualitative detection of the SARS-CoV-2 nucleocapsid protein antigen in nasopharyngeal swab samples. Sensitivity 97.30%, specificity 100%. Manufactured in Austria.

In vitro diagnostic medical device — professional use and home testing

Request an offer

Description

A rapid immunochromatographic test for the qualitative detection of the SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab samples, as an aid in the rapid and efficient diagnosis of COVID-19. Manufacturer: AMEDA Labordiagnostik GmbH, Graz, Austria.

  • Sensitivity: 97.30%
  • Specificity: 100%
  • Pack: 10 tests per box, cassettes individually sealed

Intended use

  • Medical practices, laboratories and point-of-care testing
  • Home testing

Frequently asked questions

Who may perform the test?

The test is intended for professional use and for home testing, following the manufacturer's instructions for use. In professional settings, sampling and interpretation are carried out by qualified medical staff.